Literature DB >> 24679059

Collective asymmetric synthesis of (-)-antofine, (-)-cryptopleurine, (-)-tylophorine, and (-)-tylocrebrine with tert-butanesulfinamide as a chiral auxiliary.

Yanlong Zheng1, Yuxiu Liu, Qingmin Wang.   

Abstract

A collective asymmetric synthesis of phenanthroindolizidine and phenanthroquinolizidine alkaloids (-)-antofine, (-)-cryptopleurine, (-)-tylophorine, and (-)-tylocrebrine was achieved by means of a reaction sequence involving efficient generation of chiral homoallylic amine intermediates by asymmetric allylation of the corresponding tert-butanesulfinyl imine. From these intermediates, the pyrrolidine and piperidine rings were constructed by means of an intramolecular SN2 substitution reaction and a ring-closing metathesis reaction, respectively. The unusual C5-methoxy-substituted phenanthrene moiety of (-)-tylocrebrine was generated by means of an InCl3-catalyzed cycloisomerization reaction of an o-propargylbiaryl compound.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24679059     DOI: 10.1021/jo500013e

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Enantioselective, Catalytic Multicomponent Synthesis of Homoallylic Amines Enabled by Hydrogen-Bonding and Dispersive Interactions.

Authors:  Elisabetta Ronchi; Shauna M Paradine; Eric N Jacobsen
Journal:  J Am Chem Soc       Date:  2021-05-05       Impact factor: 15.419

Review 2.  Applications of tert-butanesulfinamide in the synthesis of N-heterocycles via sulfinimines.

Authors:  Rose Mary Philip; Sankaran Radhika; P V Saranya; Gopinathan Anilkumar
Journal:  RSC Adv       Date:  2020-11-23       Impact factor: 4.036

3.  Synthesis, Structure-Activity Relationships, and Parasitological Profiling of Brussonol Derivatives as New Plasmodium falciparum Inhibitors.

Authors:  Camila S Barbosa; Anees Ahmad; Sarah El Chamy Maluf; Igor M R Moura; Guilherme E Souza; Giovanna A H Guerra; Roberto R Moraes Barros; Marcos L Gazarini; Anna C C Aguiar; Antonio C B Burtoloso; Rafael V C Guido
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.